Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neonatal Perinatal Med ; 10(1): 119-123, 2017.
Article in English | MEDLINE | ID: mdl-28304319

ABSTRACT

Infant delirium is an under-recognized clinical entity in neonatal intensive care, and earlier identification and treatment could minimize morbidities associated with this condition. We describe a case of a 6-month-old former 32 weeks gestation infant undergoing a prolonged mechanical ventilation course diagnosed with delirium related to the combination of his underlying illness and the use of multiple sedative and analgesic medications. Initiation of the atypical antipsychotic risperidone allowed for weaning from continuous infusions of benzodiazepines and opiods, and lower dosages of bolus-dosed sedation and analgesics. The patient experienced no adverse side effects from use of this neuroleptic.


Subject(s)
Analgesics, Opioid/adverse effects , Cardiac Catheterization , Delirium/therapy , Deprescriptions , Hypnotics and Sedatives/adverse effects , Postoperative Complications/therapy , Respiratory Distress Syndrome, Newborn/psychology , Amines/therapeutic use , Anti-Anxiety Agents/therapeutic use , Cyclohexanecarboxylic Acids/therapeutic use , Delirium/etiology , Dexmedetomidine/adverse effects , Diazepam/adverse effects , Female , Fentanyl/adverse effects , Gabapentin , Humans , Infant , Infant, Newborn , Infant, Premature , Intensive Care Units, Neonatal , Methadone/adverse effects , Midazolam/adverse effects , Phenobarbital/adverse effects , Postoperative Complications/etiology , Pregnancy , Respiration, Artificial , Respiratory Distress Syndrome, Newborn/complications , Risperidone/therapeutic use , gamma-Aminobutyric Acid/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...